| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000030278 |
| Receipt No. | R000034584 |
| Official scientific title of the study | Prognostic impact of inflammatory-related biomarkers on the overall survival of patients with non-operable malignant pleural mesothelioma |
| Date of disclosure of the study information | 2017/12/07 |
| Last modified on | 2017/12/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Prognostic impact of inflammatory-related biomarkers on the overall
survival of patients with non-operable malignant pleural mesothelioma |
|
| Title of the study (Brief title) | Prognostic impact of inflammatory-related biomarkers on the overall
survival of patients with non-operable malignant pleural mesothelioma |
|
| Region |
|
|
| Condition | ||
| Condition | malignant pleural mesothelioma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We aimed to assess the prognostic utilities of inflammatory-related biomarkers in non-operable MPM patients. |
| Basic objectives2 | Others |
| Basic objectives -Others | none |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | overall survival |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The medical records of consecutive patients with histologically confirmed malignant pleural mesothelioma (MPM) between January 2007 and August 2017 in our hospital were reviewed retrospectively. | |||
| Key exclusion criteria | MPM patients who received surgical treatment were excluded from this study. Patients who had active inflammatory disease (such as rheumatoid arthritis) or infection at the time of MPM diagnosis were excluded. Patients who were treated by chemotherapy or radiotherapy before the histological diagnosis of MPM, patients with MPM confirmed by autopsy, patients who had entered clinical trial study, patients with insufficient follow-up period (patients with follow-up period of less than one month after the diagnosis of MPM or patients who had received treatment at other hospitals after the diagnosis of MPM), were also excluded. | |||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Takehiro Otoshi |
| Organization | Hyogo Prefectural Amagasaki General Medical Center |
| Division name | Department of Respiratory Medicine |
| Address | 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo 660-8550, Japan |
| TEL | +81-(0)6-6480-7000 |
| takehiro-otoshi19850902@gmail.com | |
| Public contact | |
| Name of contact person | Takehiro Otoshi |
| Organization | Hyogo Prefectural Amagasaki General Medical Center |
| Division name | Department of Respiratory Medicine |
| Address | 2-17-77 Higashinaniwa-cho, Amagasaki, Hyogo 660-8550, Japan |
| TEL | +81-(0)6-6480-7000 |
| Homepage URL | |
| takehiro-otoshi19850902@gmail.com | |
| Sponsor | |
| Institute | Hyogo Prefectural Amagasaki General Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hyogo Prefectural Amagasaki General Medical Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | A retrospective observational study in a single center |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034584 |